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orophylactic Coronary
ngiography Improves Outcome
fter Major Vascular Surgery
n a study published recently in the Journal, Monaco et al. (1)
howed that routine coronary angiography positively impacted
ong-term outcome of peripheral arterial disease surgical patients
t medium-high risk.
I find it difficult to adopt this study’s results for the following
easons. Two randomized studies showed no benefit for percu-
aneous coronary intervention (PCI) in elective patients under-
oing vascular surgery (2,3). Actually, despite numerous at-
empts, no randomized study to date has shown PCI to improve
lective patient prognosis (4 –8). A diagnostic procedure (e.g.,
oronary angiography) should not be expected to improve
atient prognosis, unless followed by an intervention (e.g.,
CI). In the current study (1), however, the differences in PCI
ate in the “systematic strategy” compared with the “selective strategy”
roup was very small: 61 (58%) versus 42 (40%), respectively. To reach
tatistical significance, therefore, the impact of PCI on a patient’s
rognosis should be huge. Considering the previous studies, I find
t unlikely.
Furthermore, long-term dual-antiplatelet therapy is currently
he standard treatment for patients undergoing coronary artery
tenting. That may postpone surgery for a significant time because
f increased bleeding risk.
We definitely need a multicenter trial to resolve this issue. Until
he results of such a trial are available, we should continue to
ractice according to current guidelines (9) and not change practice
s a result of this study.
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rophylactic Pre-Operative
oronary Revascularization
o We Have the Data?
onaco et al. (1) propose a new diagnostic and treatment
lgorithm for patients undergoing major elective vascular surgery
ith a revised cardiac risk index (RCRI) 2: routine coronary
ngiography followed by extensive revascularization. In their dis-
ussion, the authors presumed that this algorithm yielded superior
esults (when compared with the conventional algorithm of selec-
ive coronary angiography based on noninvasive stress imaging)
ecause “. . . noninvasive testing missed a substantial portion of
atients with coronary artery disease (CAD).”
This statement is not substantiated by the study. The authors
ould have extracted the data in an attempt to support or validate
his statement by comparing the negative predictive values of
he 2 strategies. It is common teaching that both noninvasive
ests (2,3) employed in this study for the “selective strategy”
ave excellent negative predictive values and low positive
redictive value and can enhance the value of selective revascu-
arization in ischemic patients (4).
Because of the very few cardiovascular events and because there
as no significant difference between the 2 arms in the frequency
f myocardial infarctions (3.9 vs. 1.9, p  0.5), the quality of the
aper could have been enhanced by precise description and
